MHC-I Peptide Identification via Chaperone Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying antigenic peptides that bind to MHC-I molecules are inefficient, with up to 80% peptide loss during purification and non-specific peptide recovery, making it challenging to attribute peptides to specific MHC-I alleles, especially in samples with low MHC-I expression.
Innovation Solution
A method involving peptide receptive MHC-I complexes affixed to a solid substrate, contacted with peptides of interest, and then purified using a molecular chaperone like TAPBPR, allowing for selective peptide binding and elution, followed by mass spectrometry for identification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of substance
If standard acid elution protocols are used for peptide purification, then the purification process can be completed, but up to 80% of relevant peptides are lost during the process
Solution Approach 1:
The patent introduces a molecular chaperone (such as TAPBPR or tapasin) as an intermediary component that forms a stable complex with MHC-I molecules. This chaperone-mediated complex serves as a protective intermediary during purification, preventing peptide loss that occurs with standard acid elution protocols. The chaperone acts as a mediator between the MHC-I molecule and the purification process, enabling gentle elution conditions that preserve peptide integrity.
Solution Approach 2:
The patent employs parameter changes by modifying the elution conditions from harsh acid-based protocols to gentler conditions enabled by chaperone presence. The chaperone allows elution at higher pH levels and lower temperatures, fundamentally changing the physical-chemical parameters of the purification process to prevent peptide degradation and loss.
2Quantity of substance
If acid extraction is used to recover peptides from cell surface or cell lysate, then peptides can be obtained, but a significant number of recovered peptides are non-specific for MHC-I
Solution Approach 1:
The molecular chaperone serves as a specific intermediary that recognizes and binds only to MHC-I molecules through their peptide-binding groove. This chaperone-MHC-I complex acts as a selective filter, ensuring that only peptides genuinely associated with MHC-I are recovered. The chaperone mediates specific recognition, preventing non-specific peptide recovery that plagues acid extraction methods.
Solution Approach 2:
The patent selectively extracts peptides specifically associated with MHC-I molecules by using the chaperone-MHC-I complex as a selective capture system. The chaperone enables specific extraction of authentic MHC-I peptides while leaving non-specific peptides behind, thereby improving measurement precision and peptide specificity.
3Measurement precision
If conventional methods are used for MHC-I peptidome analysis, then peptide identification can be performed, but it is difficult to attribute identified peptides to particular MHC-I alleles, especially in samples with low MHC-I expression
Solution Approach 1:
The molecular chaperone acts as an amplifying intermediary that stabilizes MHC-I molecules even at low expression levels. By forming stable chaperone-MHC-I complexes, the system enhances the detectable quantity of MHC-I molecules without requiring high endogenous expression. This intermediary effect enables reliable allele attribution even in samples with limited MHC-I expression.
Solution Approach 2:
The patent performs preliminary stabilization of MHC-I molecules through chaperone binding before the actual peptide analysis. This preliminary action ensures that even low-abundance MHC-I molecules are preserved and stabilized, enabling subsequent accurate attribution to specific alleles during mass spectrometry analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances peptide recovery and selectivity, reducing peptide loss and improving attribution to specific MHC-I alleles, even in samples with low MHC-I expression, leading to more accurate antigenic peptide identification.
Implementation Method 1
contacting the peptide receptive MHC-I complex with a molecular chaperone
Implementation Method 2
purifying the peptide-MHC-I complex
Data Source
AI summary
Provided herein are novels systems and methods for the identification of peptides that bind to MHC-I molecules using peptide receptive MHC-I complexes.